PDT Partners LLC reduced its holdings in VAREX IMAGING (NASDAQ:VREX - Free Report) by 48.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 58,385 shares of the company's stock after selling 53,959 shares during the period. PDT Partners LLC owned about 0.14% of VAREX IMAGING worth $677,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Aquatic Capital Management LLC acquired a new stake in VAREX IMAGING during the fourth quarter valued at $25,000. Point72 Hong Kong Ltd acquired a new stake in shares of VAREX IMAGING during the 4th quarter valued at about $48,000. Quarry LP purchased a new position in shares of VAREX IMAGING in the 1st quarter valued at about $63,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in VAREX IMAGING by 58.0% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,279 shares of the company's stock worth $131,000 after purchasing an additional 4,139 shares during the period. Finally, ProShare Advisors LLC acquired a new position in VAREX IMAGING in the 4th quarter worth about $159,000.
Wall Street Analyst Weigh In
VREX has been the subject of a number of recent analyst reports. B. Riley restated a "buy" rating and issued a $16.00 price objective (up from $12.00) on shares of VAREX IMAGING in a research report on Friday, August 8th. Wall Street Zen downgraded shares of VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 9th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $19.50.
Get Our Latest Research Report on VREX
VAREX IMAGING Price Performance
Shares of NASDAQ:VREX traded down $0.01 during midday trading on Friday, hitting $11.65. 261,313 shares of the stock were exchanged, compared to its average volume of 516,385. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78. The company has a 50 day moving average price of $9.24 and a 200-day moving average price of $9.38. VAREX IMAGING has a twelve month low of $6.76 and a twelve month high of $16.93. The stock has a market cap of $483.48 million, a P/E ratio of 16.64 and a beta of 0.87.
VAREX IMAGING (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.14. VAREX IMAGING had a negative net margin of 16.13% and a positive return on equity of 5.54%. The company had revenue of $203.00 million for the quarter, compared to analysts' expectations of $190.32 million. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. On average, research analysts forecast that VAREX IMAGING will post 0.53 earnings per share for the current year.
About VAREX IMAGING
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Recommended Stories

Before you consider VAREX IMAGING, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VAREX IMAGING wasn't on the list.
While VAREX IMAGING currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.